Eris Biotech
Our drugs engage the immune system to fight tumors
Eris Biotech is a business in healthcare based in Lehi, UT, USA.
Profile
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
As a business in healthcare, Eris Biotech is listed here with the public details available about it.
The company is recorded as being based in Lehi, UT, USA.
It is recorded at the Winter 2024 stage.
The company reports a headcount in the 2 range.
Directory analysis
Eris Biotech is a U.S.-based biotech company developing small‑molecule inhibitors that block immune suppression to activate the immune system against cancer. Their therapeutic pipeline targets solid tumors, with an initial focus on mesothelioma. The company is very early stage with only a handful of employees.
Positioning: Eris Biotech operates in a highly competitive oncology space, concentrating on a niche mechanism of action that could complement existing immunotherapies. With limited public data and a small team, its commercial prospects remain uncertain and require further development milestones.
Note: Eris Biotech is a small U.S. biotech focused on immune‑modulating small molecules for solid tumors.
Auto-generated directory analysis from public data · updated 10 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | Lehi, UT, USA |
| Country | USA |
| Employees | 2 |
| Stage | Winter 2024 |
Website: www.erisbio.com
Browse related
Create a free account